Trial Profile
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; Atazanavir/ritonavir; Emtricitabine; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms IDEAL
- 28 May 2013 NCT reports actual initiation date is 1 Aug 2011.
- 28 May 2013 Planned End Date changed from 1 Aug 2013 to 1 Oct 2016 as reported by ClinicalTrials.gov.
- 21 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2010-022413-26).